A Study to Evaluate the Safety and Tolerability of Using the SHR-1210 by Advanced Solid Tumor Subjects
Clinical trial NCT02721589 · COMPLETED
Trial details
- NCT number
- NCT02721589
- Sponsor
- Jiangsu HengRui Medicine Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2016-04-06
- Primary completion
- 2019-11-17
- Enrollment
- 126
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.